Preoperative Bevacizumab and Trastuzumab With ABI-007 and Carboplatin in HER2+ Breast Cancer
Clinical trial NCT00392392 · COMPLETED
Trial details
- NCT number
- NCT00392392
- Sponsor
- SCRI Development Innovations, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-10-01
- Primary completion
- 2008-04-01
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.